Click “Continue” below for instant access
Welcome to Breakthrough Investor. We've rushed a copy to your email inbox!
You can find the latest research by clicking the button below, but first, as our thank you for signing up, you may add any of the following bonus reports completely free of charge.
——————
*Free Bonus Reports* Select any of these complimentary hand-selected reports and they'll be sent to your inbox right away.
(Continue to the next page)
Today’s Market Snapshot U.S. stocks drifted yesterday as bullish AI chatter clashed with mixed signals from cyclical earnings, leaving major indexes pinned near the flatline.
Introduction Cybin Inc., doing business as Helus Pharma, is a clinical-stage biopharmaceutical company focused on novel psychedelic-based therapeutics for mental health (www.otcmarkets.com). In January 2026
Opening Recap Market Pulse: Equities drifted higher yesterday despite the Fed’s tame commentary, with tech wobbling on Tesla’s earnings jitters while broader sectors held firm.
